The Multilateral Leaders Taskforce on COVID-19 (MLT), says there is inequity in vaccination between low-income and high income countries
The task force, made up of heads of the International Monetary Fund (IMF), World Bank Group, World Health Organisation (WHO) and World Trade Organisation (WTO) issued a statement on Friday in Geneva and Washington DC.
According to it, it held a meeting with leaders of the African Vaccine Acquisition Trust (AVAT), Africa Center for Disease Control (CDC), Gavi and United Nations Education Fund (UNICEF).
The task force said that less than two per cent of adults were fully vaccinated in most low-income countries compared to almost 50 per cent in high income countries.
It said that the low income countries simply could not access sufficient vaccine to meet even the global goals of 10 per cent coverage in all countries by September and 40 per cent by end of 2021, let alone the African Union’s goal of 70 per cent in 2022.
“This crisis of vaccine inequity is driving a dangerous divergence in COVID-19 survival rates and in the global economy. We appreciate the important work of AVAT and COVAX to try and address this unacceptable situation.
“However, effectively tackling this acute vaccine supply shortage in low- and lower middle-income countries, and fully enabling AVAT and COVAX, requires the urgent cooperation of vaccine manufacturers, vaccine-producing countries and countries that have already achieved high vaccination rates.”
It said that to ensure all countries achieve the set global vaccination goals, all countries that had contracted high volumes of vaccines should swap near-term delivery schedules with COVAX and AVAT.
It also called on vaccine manufacturers to immediately prioritise and fulfill their contracts to COVAX and AVAT and provide regular, clear supply forecasts.
The group also urged G7 and all dose-sharing countries to fulfill their pledges urgently, with enhanced pipeline visibility, product shelf life and support for ancillary supplies, as barely 10 per cent of nearly 900 million committed doses had so far been shipped.
“We call on all countries to eliminate export restrictions and any other trade barriers on COVID-19 vaccines and the inputs involved in their production.
“We are in parallel intensifying our work with COVAX and AVAT to tackle persistent vaccine delivery, manufacturing and trade issues, notably in Africa and mobilise grants and concessional financing for these purposes.
“We will also explore financing mechanisms to cover future vaccine needs as requested by AVAT.
“We will advocate for better supply forecasts and investments to increase country preparedness and absorptive capacity.”
It added that it would continue to enhance its data, to identify gaps and improve transparency in the supply and use of all COVID-19 tools.
“The time for action is now. The course of the pandemic—and the health of the world—are at stake”, it said.
It was reported that the task force was established to identify and resolve finance and trade impediments to vaccine, diagnostics, therapeutic production and deliveries.